Chemical circularization of in vitro transcribed RNA for exploring circular mRNA design.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40651943.
- Also identified by DOI 10.1038/s41467-025-61775-1 and PMC identifier 12255688.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Circularization is an important step for therapeutic messenger RNA (mRNA) enhancements. Current enzymatic and ribozymatic-based circularization methods face limitations including sequence constraints, purification challenges, and sub-optimal biological activity. Chemical strategies, while promising, have been restricted to short RNA sequences. Here, we report a method for chemically circularized in vitro transcribed RNAs of various lengths (chem-circRNAs; 35-4000 nt) with circularization efficiencies reaching up to 60%. This approach leverages a 5' ethylenediamine modification and a periodate-oxidized 3' end to drive intramolecular reductive amination. We demonstrate that this method is applicable to various sequences and modification compatible. We report the effective separation methods of chem-circRNAs from their linear precursors. We show that protein-coding chem-circRNAs are translationally active in cells and exhibit increased durability, like enzymatically circularized mRNAs. Furthermore, our method allows incorporation of functional modifications, including endocyclic N7-methylguanosine cap and N1-methylpseudouridine, enabling access to chemically defined translationally active circRNAs for therapeutic applications.
Medical subject headings
- RNA, Circular
- RNA, Messenger